ANGIOTENSIN CONVERTING ENZYME-INHIBITION AND VASCULAR HYPERTROPHY IN HYPERTENSION

被引:40
|
作者
GIBBONS, GH [1 ]
DZAU, VJ [1 ]
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV VASC MED & ATHEROSCLEROSIS,75 FRANCIS ST,BOSTON,MA 02115
关键词
angiotensin; converting enzyme inhibitors; hypertension; hypertrophy; vascular smooth muscle;
D O I
10.1007/BF01857638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pathogenesis of hypertension is associated with a remodeling of vascular structure. Folkow has postulated that the decreased luminal area and thickened medial layer in hypertensive vessels enhances the vasoconstrictive response to vasoactive agents. It is hypothesized that this increase in vascular reactivity may serve to perpetuate hypertension. A growing body of evidence suggests that autocrineparacrine vasoactive substances and growth factors modulate vascular structure in hypertension. We speculate that therapeutic interventions that normalize blood pressure as well as reverse the vascular remodeling process may have special clinical value. The role of the paracrine renin-angiotensin system and angiotensin converting enzyme inhibitors in hypertension is discussed in this context. © 1990 Kluwer Academic Publishers.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 50 条
  • [41] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION, CATECHOLAMINES AND HEMODYNAMICS IN ESSENTIAL-HYPERTENSION
    MUIESAN, G
    ALICANDRI, CL
    AGABITIROSEI, E
    FARIELLO, R
    BESCHI, M
    BONI, E
    CASTELLANO, M
    MONITI, E
    MUIESAN, L
    ROMANELLI, G
    ZANIELLI, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06): : 1420 - 1424
  • [42] ANGIOTENSIN CONVERTING ENZYME-INHIBITION, PARASYMPATHETIC ACTIVITY AND EXERCISE IN ESSENTIAL-HYPERTENSION
    FARIELLO, R
    ALICANDRI, C
    BONI, E
    ZANINELLI, A
    CANTALAMESSA, A
    CORDA, L
    MUIESAN, G
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1989, 15 (11-12) : 571 - 576
  • [43] THE PHARMACOKINETICS AND ANGIOTENSIN CONVERTING ENZYME-INHIBITION DYNAMICS OF CILAZAPRIL IN ESSENTIAL-HYPERTENSION
    MEREDITH, PA
    ELLIOTT, HL
    REID, JL
    FRANCIS, RJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 : S263 - S266
  • [44] ANGIOTENSIN CONVERTING ENZYME-INHIBITION IMPROVES DIAGNOSTIC PROCEDURES FOR RENOVASCULAR HYPERTENSION IN DOGS
    JONKER, GJ
    DEZEEUW, D
    HUISMAN, RM
    PIERS, DB
    BEEKHUIS, H
    VANDERHEM, GK
    HYPERTENSION, 1988, 12 (04) : 411 - 419
  • [45] THE PROLIFERATIVE RESPONSE TO VASCULAR INJURY IS SUPPRESSED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITION
    POWELL, JS
    MULLER, RKM
    ROUGE, M
    KUHN, H
    HEFTI, F
    BAUMGARTNER, HR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 : S42 - S49
  • [46] PREVENTION OF STRUCTURAL-CHANGES IN THE HEART IN HYPERTENSION BY ANGIOTENSIN CONVERTING ENZYME-INHIBITION
    TAN, LB
    BRILLA, C
    WEBER, KT
    JOURNAL OF HYPERTENSION, 1992, 10 : S31 - S34
  • [47] THERAPEUTIC ASSESSMENT OF URAPIDIL OR ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN SYSTEMIC HYPERTENSION
    ROSENTHAL, J
    HAERLIN, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (07): : D25 - D29
  • [48] CARDIAC AND VASCULAR EFFECTS OF CHRONIC ANGIOTENSIN CONVERTING ENZYME-INHIBITION AT SUBANTIHYPERTENSIVE DOSES
    GOHLKE, P
    STOLL, M
    LAMBERTY, V
    MATTFELD, T
    MALL, G
    VANEVEN, P
    MARTORANA, P
    UNGER, T
    JOURNAL OF HYPERTENSION, 1992, 10 : S141 - S144
  • [49] SERUM MAGNESIUM IS UNAFFECTED BY ANGIOTENSIN CONVERTING ENZYME-INHIBITION
    VANDENBURG, MJ
    ROBINSON, P
    ARR, S
    COOPER, WD
    CURRIE, WJC
    CLINICAL SCIENCE, 1985, 68 : P77 - P78
  • [50] ANGIOTENSIN CONVERTING ENZYME-INHIBITION - A NEW THERAPEUTIC MODALITY
    GAVRAS, H
    CHAROCOPOS, F
    BRUNNER, H
    GAVRAS, I
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1981, 57 (04) : 304 - 310